WashU Sequencing Breast Cancer Tumors to Determine Genomic Profile of Aromatase Inhibitor Response

The study is part of an ongoing clinical trial, conducted by the American College of Surgeons Oncology Group, that involves more than 300 postmenopausal women with estrogen-positive stage II or II breast cancer at the time of diagnosis.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.